Emmaus Medical Announces Completion of All Patient Visits For Its Phase 3 Clinical Trial For Treatment of Sickle Cell DiseaseJanuary 07, 2014 Read More
Emmaus Life Sciences Cancels Stock Held By AFH Holding & Advisory and Amir HeshmatpourJuly 01, 2013 Read More
Emmaus Life Sciences Wins Sweeping Summary Judgment Victory In Suit Against AFH Holding & Advisory and Amir HeshmatpourMay 16, 2013 Read More
